Stephan Hold

Background

About Stephan Hold

Head of R&D Clinical Chemistry | Expert in Analytical Method Development | Scientific Leader I am an accomplished scientist with extensive experience in developing and validating cutting-edge analytical methods for complex substances and challenging products. My expertise spans a range of techniques, including HPLC-UV, GC- and LC-MS/MS, and universal detectors, with a strong foundation in Analytical Quality by Design (AQbD) approaches. Currently, I serve as the Head of R&D Clinical Chemistry at Archimedlife, a private clinical laboratory specializing in rare metabolic diseases. My work has significantly contributed to advancing diagnostic assays for lysosomal storage diseases and other rare disorders. Prior to this, I honed my skills as an analytical scientist at Novartis, focusing on the development of oncology therapies, and at Archimedlife, developing innovative assays to meet the unmet needs of rare disease diagnostics. I pride myself on maintaining a scientific mindset, fostering innovation, and embracing challenges in analytical science. Leadership comes naturally to me—I thrive in guiding teams to achieve excellence in R&D projects, aligning efforts with both scientific rigor and business goals. With a keen spirit for discovery and a commitment to pushing the boundaries of clinical and analytical chemistry, I am passionate about delivering solutions that make a meaningful difference in healthcare. Let's connect to explore opportunities in advancing science and innovation!